Amphastar Pharmaceuticals, Inc.
Quick facts
| Founded | 1996 |
|---|
Marketed products
- Epinephrine inhalation · Pulmonology / Respiratory
Epinephrine inhalation is a bronchodilator that stimulates alpha and beta-adrenergic receptors to rapidly relieve acute bronchospasm and airway obstruction. - Placebo DPI
Placebo DPI is an inert formulation delivered via dry powder inhaler that produces no pharmacological effect. - Primatene Mist · Respiratory
Epinephrine acts as a beta-2 adrenergic agonist to relax bronchial smooth muscle and relieve acute bronchospasm.
Phase 3 pipeline
- albuterol inhalation aerosol · Respiratory
Albuterol inhalation aerosol is a beta-2 adrenergic receptor agonist that works by relaxing bronchial muscles to improve airflow to the lungs. - albuterol inhalation powder · Respiratory
Albuterol is a beta-2 adrenergic agonist that binds to beta-2 receptors on airway smooth muscle, causing relaxation and bronchodilation. - Epinephrine HFA-MDI (E004) · Pulmonary / Emergency Medicine
Epinephrine is a sympathomimetic amine that binds to alpha and beta adrenergic receptors to produce rapid bronchodilation, increased heart rate, and vasoconstriction. - epinephrine inhalation aerosol · Respiratory
Epinephrine inhalation aerosol works by stimulating the beta-2 adrenergic receptors in the lungs to cause bronchodilation.
Phase 2 pipeline
- A006 · Diabetes
A006 is a small molecule that acts as a selective inhibitor of the sodium-glucose cotransporter 2 (SGLT2). - A006 DPI
- Arm T1: Primatene Mist HFA · Respiratory
Primatene Mist HFA is a bronchodilator that contains epinephrine, which works by relaxing the muscles in the airways and increasing air flow to the lungs. - Arm T2: Primatene Mist HFA
- I004
- Proventil® MDI
Phase 1 pipeline
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: